August 3, 2025

Critical role of ongoing EA9181 trial for Ph+ ALL highlighted in Blood Cancers Today

July 16, 2025

European Hematology Association highlights E1910 data showing improved survival in younger B-cell ALL patients aged 30-54

July 15, 2025

Consolidation blinatumomab with chemotherapy improves survival in younger B-cell ALL patients aged 30-54 (study E1910)

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

September 26, 2024

The Fall 2024 advocacy blog Considering Clinical Trials is now available

August 21, 2024

How a patient’s role in a clinical trial for acute lymphocytic leukemia brought a cancer-free diagnosis, FDA approval

August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

July 24, 2024

Press Release: New England Journal of Medicine publishes practice-changing E1910 trial results

ECOG-ACRIN Cancer Research Group